Catalyst Pharmaceuticals, Inc.

Wealthspire Advisors, LLC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

37,160

Value ($000)

867

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	867	0.0%	37,160	12/31/2025
2025 Q3	11/14/2025	726	0.0%	36,843	9/30/2025
2025 Q2	8/11/2025	800	0.0%	36,879	6/30/2025
2025 Q1	5/9/2025	835	0.0%	34,434	3/31/2025
2024 Q4	2/4/2025	717	0.0%	34,355	12/31/2024
2024 Q3	11/13/2024	681	0.0%	34,271	9/30/2024
2024 Q2	8/8/2024	562	0.0%	36,292	6/30/2024
2024 Q1	5/6/2024	578	0.0%	36,292	3/31/2024
2023 Q4	2/7/2024	610	0.0%	36,292	12/31/2023
2023 Q3	11/6/2023	424	0.0%	36,292	9/30/2023
2023 Q2	8/1/2023	528	0.0%	39,270	6/30/2023
2023 Q1	5/9/2023	651	0.0%	39,270	3/31/2023
2022 Q4	2/14/2023	645	0.0%	34,656	12/31/2022
2022 Q3	11/14/2022	440	0.0%	34,270	9/30/2022
2022 Q2	8/9/2022	580	0.0%	82,770	6/30/2022
2022 Q1	5/9/2022	686	0.0%	82,770	3/31/2022
2021 Q4	2/14/2022	933	0.0%	137,770	12/31/2021
2021 Q3	11/15/2021	1,790	0.0%	337,770	9/30/2021
2021 Q2	8/13/2021	1,942	0.1%	337,770	6/30/2021
2021 Q1	5/17/2021	1,557	0.0%	337,770	3/31/2021
2020 Q4	2/16/2021	1,128	0.0%	337,770	12/31/2020
2020 Q3	11/16/2020	1,003	0.1%	337,770	9/30/2020
2020 Q2	8/14/2020	1,560	0.1%	337,770	6/30/2020
2020 Q1	5/12/2020	1,300	0.1%	337,770	3/31/2020